Correlations between p53-protein accumulation, serum antibodies and gene mutation in colorectal cancer

International Journal of Cancer

Volumn 81, Issue 5, 1999, Pages 712-718

  Hammel, Pascal ^a   Leroy Viard, Karen ^b   Chaumette, Marie Thérèse ^b   Villaudy, Jacqueline ^c   Falzone, Marie Claude ^b   Rouillard, Dany ^c   Hamelin, Richard ^d   Boissier, Brigitte ^b   Remvikos, Yorghos ^c  

^a BEAUJON HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c INSTITUT CURIE   (France)

^d CEPH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN ANTIBODY; PROTEIN P53;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION FUNCTION; DIPLOIDY; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; MALE; POLYPLOIDY; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, NEOPLASM; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; POLYPLOIDY; PROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032908996     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990531)81:5<712::AID-IJC7>3.0.CO;2-0     Document Type: Article

References (21)

1. ANGELOPOULOU, K., STRATIS, M. and DIAMANDIS, E.P., Humoral immune response against p53 protein in patients with colorectal carcinomas. Int. J. Cancer, 70, 46-51 (1997).
2. DAVIDOFF, A.M., IGLEHART, J.D. and MARKS, J.R., Immune response to p53 is dependant upon p53/HSP70 complexes in breast cancers. Proc. nat. Acad. Sci. (Wash.), 89, 3439-3442 (1992).
3. GUINEE, D.G. JR and 15 OTHERS, Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression. Carcinogenesis, 16, 993-1002 (1995).
4. HALL, P.A. and LANE, D.P., p53 in tumour pathology: can we trust immunohistochemistry? - revisited. J. Pathol., 172, 1-4 (1994).
5. HAMELIN, R., LAURENT-PUIG, P., OLSCHWANG, S., JEGO, N., ASSELAIN, B., REMVIKOS, Y., GIRODET, J., SALMON, R.J. and THOMAS, G., Association of p53 mutations with short survival in colorectal cancer. Gastroenterology, 106, 42-48 (1994).
6. HAMMEL, P., BOISSIER, B., CHAUMETTE, M.T., PIEDBOIS, P., ROTMAN, N., KOUYOUMDJIAN, J.C., LUBIN, R., DELCHIER, J.C. and SOUSSI, T., Detection and monitoring of serum p53 antibodies in patients with colorectal cancer. Gut, 40, 356-361 (1997).
7. HOUBIERS, J.G.A., VAN DER BURG, S.H., VAN DE WATERING, L.M.G., TOLLENAAR, R.A.E.M., BRAND, A., VAN DE VELDE, C.J.H. and MELIEF, C.J.M., Antibodies against p53 are associated with poor prognosis of colorectal cancer. Brit. J. Cancer, 72, 637-641 (1995).
8. LEGROS, Y., LAFON, C. and SOUSSI, T., Linear antigenic sites defined by the B-cell response to human p53 are localized predominantly in the amino and carboxy termini of the protein. Oncogene, 9, 2071-2076 (1994).
9. LUBIN, R., SCHLICHTHOLZ, B., TEILLAUD, J.L., GARAY, E., BUSSEL, A., WILD, C.P. and SOUSSI, T., p53 antibodies in patients with various types of cancer: identification and characterization. Clin. Cancer Res., 1, 1463-1469 (1995a).
10. LUBIN, R., ZALCMAN, G., BOUCHET, L., TRÉDANEL, J., LEGROS, Y., CAZALS, D., HIRSCH, A. and SOUSSI, T., Serum p53 antibodies as early markers of lung cancer. Nature Med., 1, 701-702 (1995b).
11. PREUDHOMME, C., LUBIN, R., LEPELLEY, P., VANRUMBEKE, M. and FENAUX, P., Detection of serum anti-p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia. Leukemia, 8, 1589-1591 (1994).
12. REMVIKOS, Y., MULERIS, M., SALMON, R.J. and DUTRILLAUX, B., Colorectal carcinogenesis: from chromosomal evolution pathways to molecular pathogenesis. Cancer Genet. Cytogenet., 93, 63-73 (1997).
13. REMVIKOS, Y., TOMINAGA, O., HAMMEL, P., LAURENT-PUIG, P., SALMON, R.J., DUTRILLAUX, B. and THOMAS, G., Increased p53 protein content of colorectal tumours correlates with poor survival. Brit. J. Cancer, 66, 758-764 (1992).
14. SCHLICHTHOLZ, B., LEGROS, Y., GILLET, D., GAILLARD, C., MARTY, M., LANE, D., CALVO, F. and SOUSSI, T., The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. Cancer Res., 52, 6380-6384 (1992).
15. SCHLICHTHOLZ, B., TRÉDANIEL, J., LUBIN, R., ZALCMAN, G., HIRSCH, A. and SOUSSI, T., Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein. Brit. J. Cancer, 69, 809-816 (1994).
16. SOUSSI, T., LEGROS, Y., LUBIN, R., ORY, K. and SCHLICHTHOLZ, B., Multifactorial analysis of p53 alteration in human cancer: a review. Int. J. Cancer, 57, 1-9 (1994).
17. STEPHEN, C.W., HELMINEN, P. and LANE, D.P., Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody peptide interactions. J. mol. Biol., 248, 58-78 (1995).
18. TOMINAGA, O., HAMMEL, P., HAMELIN, R., NAGAWA, H., MUTO, T. and REMVIKOS, Y., Quantification and characterization of total cellular p53 protein in colorectal cancer. Cytometry, 31, 1-7 (1997).
19. VON BREVERN, M.C., HOLLSTEIN, M.C., CAWLEY, H.M., DE BENEDETTI, V.M.G., BENNETT, W.P., LIANG, L., HE, A.G., ZHU, S.M., TURSZ, T., JANIN, N. and TRIVERS, G.E., Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors. Cancer Res., 56, 4917-4921 (1996).
20. WILD, C.P., RIDANPÄÄ, M., ANTTILA, S., LUBIN, R., SOUSSI, T., HUSGAFVEL-FURSIAINEN, K. and VANINO, H., p53 antibodies in the sera of lung-cancer patients: comparison with p53 mutations in the tumour tissue. Int. J. Cancer, 64, 176-181 (1995).
21. WINTER, S.F., MINNA, J.D., JOHNSON, B.E., TAKAHASHI, T., GAZDAR, A.F. and CARBONE, D.P., Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Res., 52, 4168-4174 (1992).